121 related articles for article (PubMed ID: 16354996)
1. Examination of maternal plasma erythropoietin and activin A concentrations with regard to circulatory erythroblast levels in normal and preeclamptic pregnancies.
Troeger C; Holzgreve W; Ladewig A; Zhong XY; Hahn S
Fetal Diagn Ther; 2006; 21(1):156-60. PubMed ID: 16354996
[TBL] [Abstract][Full Text] [Related]
2. [Study on the relationship between activin A, follistatin and preeclampsia].
Zhao L; Shang T; Wang YL; Tang S; Li H; Liu ZH
Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):676-9. PubMed ID: 14728855
[TBL] [Abstract][Full Text] [Related]
3. Umbilical cord serum activin A levels are increased in pre-eclampsia with impaired blood flow in the uteroplacental and fetal circulation.
Florio P; Reis FM; Severi FM; Luisi S; Imperatore A; Palumbo MA; Bagnoli F; Gioffre W; Petraglia F
Placenta; 2006; 27(4-5):432-7. PubMed ID: 16051348
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress increases placental and endothelial cell activin A secretion.
Mandang S; Manuelpillai U; Wallace EM
J Endocrinol; 2007 Mar; 192(3):485-93. PubMed ID: 17332518
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
[TBL] [Abstract][Full Text] [Related]
6. Uterine vein and maternal urinary levels of activin A and inhibin A in pre-eclampsia patients.
Muttukrishna S; Hyett J; Paine M; Moodley J; Groome N; Rodeck C
Clin Endocrinol (Oxf); 2006 Apr; 64(4):469-73. PubMed ID: 16584522
[TBL] [Abstract][Full Text] [Related]
7. Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry.
Madazli R; Kuseyrioglu B; Uzun H; Uludag S; Ocak V
Int J Gynaecol Obstet; 2005 Jun; 89(3):251-7. PubMed ID: 15919391
[TBL] [Abstract][Full Text] [Related]
8. Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies.
Keelan JA; Taylor R; Schellenberg JC; Groome NP; Mitchell MD; North RA
Obstet Gynecol; 2002 Feb; 99(2):267-74. PubMed ID: 11814508
[TBL] [Abstract][Full Text] [Related]
9. Adhesion molecules, activin and inhibin--candidates for the biochemical prediction of hypertensive diseases in pregnancy?
Hanisch CG; Pfeiffer KA; Schlebusch H; Schmolling J
Arch Gynecol Obstet; 2004 Sep; 270(2):110-5. PubMed ID: 12898146
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of increased maternal serum total activin a and inhibin a in preeclampsia.
Silver HM; Lambert-Messerlian GM; Reis FM; Diblasio AM; Petraglia F; Canick JA
J Soc Gynecol Investig; 2002; 9(5):308-12. PubMed ID: 12383916
[TBL] [Abstract][Full Text] [Related]
11. Activin A and activin receptors in gestational tissue from preeclamptic pregnancies.
Manuelpillai U; Schneider-Kolsky M; Dole A; Wallace EM
J Endocrinol; 2001 Oct; 171(1):57-64. PubMed ID: 11572790
[TBL] [Abstract][Full Text] [Related]
12. Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia.
Diesch CH; Holzgreve W; Hahn S; Zhong XY
Prenat Diagn; 2006 Dec; 26(13):1267-70. PubMed ID: 17139698
[TBL] [Abstract][Full Text] [Related]
13. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels.
Florio P; Ciarmela P; Luisi S; Palumbo MA; Lambert-Messerlian G; Severi FM; Petraglia F
Gynecol Endocrinol; 2002 Oct; 16(5):365-72. PubMed ID: 12587530
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum activin A levels in association with intrauterine fetal growth restriction.
Wallace EM; Schneider-Kolsky ME; Edwards A; Baker L; Jenkin G
BJOG; 2003 Mar; 110(3):306-10. PubMed ID: 12628273
[TBL] [Abstract][Full Text] [Related]
15. Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin.
Bersinger NA; Smárason AK; Muttukrishna S; Groome NP; Redman CW
Hypertens Pregnancy; 2003; 22(1):45-55. PubMed ID: 12648442
[TBL] [Abstract][Full Text] [Related]
16. First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
Ong CY; Liao AW; Munim S; Spencer K; Nicolaides KH
J Matern Fetal Neonatal Med; 2004 Mar; 15(3):176-80. PubMed ID: 15280143
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum activin A is not elevated before preeclampsia in women who are at high risk.
Blackburn CA; Keelan JA; Taylor RS; North RA
Am J Obstet Gynecol; 2003 Mar; 188(3):807-11. PubMed ID: 12634661
[TBL] [Abstract][Full Text] [Related]
19. Enrichment of fetal cells and free fetal DNA from maternal blood: An insight into the Basel experience.
Holzgreve W; Zhong XY; Burk MR; Hahn S
Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):43-4. PubMed ID: 11753508
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of activin A and inhibin A are not related to the increased susceptibility to pre-eclampsia in type I diabetic pregnancies.
Ekbom P; Damm P; Andersson AM; Skakkebaek NE; Feldt-Rasmussen U; Mathiesen ER
Acta Obstet Gynecol Scand; 2006; 85(2):143-7. PubMed ID: 16532905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]